Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

KDM6A Epigenetically Regulates Subtype Plasticity in Small Cell Lung Cancer

ABSTRACT: KDM6A Epigenetically Regulates Subtype Plasticity in Small Cell Lung Cancer

PROVIDER: PRJNA949514 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21029900_1.fastq.gz	Fastqsanger.gz
	SRR21029900_2.fastq.gz	Fastqsanger.gz
	SRR21029901_1.fastq.gz	Fastqsanger.gz
	SRR21029901_2.fastq.gz	Fastqsanger.gz
	SRR21029902_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 74

Similar Datasets

KDM6A Epigenetically Regulates Subtype Plasticity in Small Cell Lung Cancer

Project description:Using a CRISPR-based autochthonous SCLC GEMM to study the consequences of KDM6A/UTX inactivation, we found that KDM6A inactivation induced plasticity from ASCL1 to NEUROD1 resulting in SCLC tumors with open chromatin at the NEUROD1 promoter that express both ASCL1 and NEUROD1. Mechanistically, KDM6A binds and maintains ASCL1 target genes in an active chromatin state with its loss increasing H3K27me3 near their promoters leading to a cell state that is primed for ASCL1 to NEUROD1 subtype switching. This work identifies KDM6A as an epigenetic regulator that controls ASCL1 to NEUROD1 subtype plasticity and provides a novel autochthonous SCLC GEMM to model ASCL1 and NEUROD1 subtype heterogeneity and plasticity, which is found in 35-40% of human SCLCs

2023-06-08 | GSE211242 | GEO

KDM6A Epigenetically Regulates Subtype Plasticity in Small Cell Lung Cancer

2023-06-08 | GSE211165 | GEO

KDM6A Epigenetically Regulates Subtype Plasticity in Small Cell Lung Cancer (scatac)

Project description:Small cell lung cancer (SCLC) exists broadly in four molecular subtypes: ASCL1, NEUROD1,POU2F3, and Inflammatory. Initially SCLC subtypes were thought to be mutually exclusive, butrecent evidence shows intra-tumoral subtype heterogeneity and plasticity between subtypes.Using a CRISPR-based autochthonous SCLC GEMM to study the consequences of KDM6A/UTXinactivation, we found that KDM6A inactivation induced plasticity from ASCL1 to NEUROD1resulting in SCLC tumors with open chromatin at the NEUROD1 promoter that express bothASCL1 and NEUROD1. Mechanistically, KDM6A binds and maintains ASCL1 target genes in anactive chromatin state with its loss increasing H3K27me3 near their promoters leading to a cell state that is primed for ASCL1 to NEUROD1 subtype switching. This work identifies KDM6A as \an epigenetic regulator that controls ASCL1 to NEUROD1 subtype plasticity and provides a novel autochthonous SCLC GEMM to model ASCL1 and NEUROD1 subtype heterogeneity and plasticity, which is found in 35-40% of human SCLCs.

2023-06-08 | GSE215828 | GEO

KDM6A Epigenetically Regulates Subtype Plasticity in Small Cell Lung Cancer

Project description:KDM6A Epigenetically Regulates Subtype Plasticity in Small Cell Lung Cancer

| PRJNA869671 | ENA

KDM6A Epigenetically Regulates Subtype Plasticity in Small Cell Lung Cancer

Project description:KDM6A Epigenetically Regulates Subtype Plasticity in Small Cell Lung Cancer

| PRJNA869124 | ENA

KDM6A Epigenetically Regulates Subtype Plasticity in Small Cell Lung Cancer.

Project description:KDM6A Epigenetically Regulates Subtype Plasticity in Small Cell Lung Cancer.

| PRJNA890674 | ENA

KDM6A Epigenetically Regulates Subtype Plasticity in Small Cell Lung Cancer (atac batch3)

2023-06-08 | GSE229152 | GEO

KDM6A Epigenetically Regulates Subtype Plasticity in Small Cell Lung Cancer (atac batch2)

2023-06-08 | GSE215827 | GEO

KDM6A Epigenetically Regulates Subtype Plasticity in Small Cell Lung Cancer (atac batch1)

Project description:Small cell lung cancer (SCLC) exists broadly in four molecular subtypes: ASCL1, NEUROD1,POU2F3, and Inflammatory. Initially SCLC subtypes were thought to be mutually exclusive, butrecent evidence shows intra-tumoral subtype heterogeneity and plasticity between subtypes.Using a CRISPR-based autochthonous SCLC GEMM to study the consequences of KDM6A/UTXinactivation, we found that KDM6A inactivation induced plasticity from ASCL1 to NEUROD1resulting in SCLC tumors with open chromatin at the NEUROD1 promoter that express bothASCL1 and NEUROD1. Mechanistically, KDM6A binds and maintains ASCL1 target genes in anactive chromatin state with its loss increasing H3K27me3 near their promoters leading to a cell state that is primed for ASCL1 to NEUROD1 subtype switching. This work identifies KDM6A as an epigenetic regulator that controls ASCL1 to NEUROD1 subtype plasticity and provides a novel autochthonous SCLC GEMM to model ASCL1 and NEUROD1 subtype heterogeneity and plasticity, which is found in 35-40% of human SCLCs.

2023-06-08 | GSE215826 | GEO

KDM6A Epigenetically Regulates Subtype Plasticity in Small Cell Lung Cancer (scatac)

Project description:KDM6A Epigenetically Regulates Subtype Plasticity in Small Cell Lung Cancer (scatac)

| PRJNA890677 | ENA